These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 9790784)

  • 1. A phase II trial of CPT-11 in recurrent squamous carcinoma of the cervix: a gynecologic oncology group study.
    Look KY; Blessing JA; Levenback C; Kohler M; Chafe W; Roman LD
    Gynecol Oncol; 1998 Sep; 70(3):334-8. PubMed ID: 9790784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II trial of 5-fluorouracil and high-dose leucovorin in recurrent adenocarcinoma of the cervix: a Gynecologic Oncology Group study.
    Look KY; Blessing JA; Valea FA; McGehee R; Manetta A; Webster KD; Andersen WA
    Gynecol Oncol; 1997 Dec; 67(3):255-8. PubMed ID: 9441772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase II study of irinotecan (CPT-11) in patients with advanced squamous cell carcinoma of the cervix.
    Irvin WP; Price FV; Bailey H; Gelder M; Rosenbluth R; Durivage HJ; Potkul RK
    Cancer; 1998 Jan; 82(2):328-33. PubMed ID: 9445190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged oral etoposide in recurrent or advanced squamous cell carcinoma of the cervix: a gynecologic oncology group study.
    Rose PG; Blessing JA; Van Le L; Waggoner S
    Gynecol Oncol; 1998 Aug; 70(2):263-6. PubMed ID: 9740702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of a European Organization for Research and Treatment of Cancer/Early Clinical Studies Group phase II trial of first-line irinotecan in patients with advanced or recurrent squamous cell carcinoma of the cervix.
    Lhommé C; Fumoleau P; Fargeot P; Krakowski Y; Dieras V; Chauvergne J; Vennin P; Rebattu P; Roche H; Misset JL; Lentz MA; Van Glabbeke M; Matthieu-Boué A; Mignard D; Chevallier B
    J Clin Oncol; 1999 Oct; 17(10):3136-42. PubMed ID: 10506610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multicenter, phase II trial of weekly irinotecan (CPT-11) in patients with previously treated colorectal carcinoma.
    Rothenberg ML; Cox JV; DeVore RF; Hainsworth JD; Pazdur R; Rivkin SE; Macdonald JS; Geyer CE; Sandbach J; Wolf DL; Mohrland JS; Elfring GL; Miller LL; Von Hoff DD
    Cancer; 1999 Feb; 85(4):786-95. PubMed ID: 10091755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase II study of gemcitabine and cisplatin in patients with advanced, persistent, or recurrent squamous cell carcinoma of the cervix.
    Burnett AF; Roman LD; Garcia AA; Muderspach LI; Brader KR; Morrow CP
    Gynecol Oncol; 2000 Jan; 76(1):63-6. PubMed ID: 10620443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II study of irinotecan in prior chemotherapy-treated squamous cell carcinoma of the cervix.
    Verschraegen CF; Levy T; Kudelka AP; Llerena E; Ende K; Freedman RS; Edwards CL; Hord M; Steger M; Kaplan AL; Kieback D; Fishman A; Kavanagh JJ
    J Clin Oncol; 1997 Feb; 15(2):625-31. PubMed ID: 9053486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cisplatin and pentoxifylline in advanced or recurrent squamous cell carcinoma of the cervix: a phase II trial of the Gynecologic Oncology Group.
    Mannel RS; Blessing JA; Boike G
    Gynecol Oncol; 2000 Oct; 79(1):64-6. PubMed ID: 11006033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II study of vinorelbine in advanced and recurrent squamous cell carcinoma of the cervix.
    Morris M; Brader KR; Levenback C; Burke TW; Atkinson EN; Scott WR; Gershenson DM
    J Clin Oncol; 1998 Mar; 16(3):1094-8. PubMed ID: 9508195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II trial of menogaril in patients with squamous carcinoma of the cervix: a Gynecologic Oncology Group study.
    Sutton GP; Blessing JA; Barrett RJ; Gallup DG
    Gynecol Oncol; 1994 Feb; 52(2):229-31. PubMed ID: 8314144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II trial of topotecan and cisplatin in persistent or recurrent squamous and nonsquamous carcinomas of the cervix.
    Fiorica J; Holloway R; Ndubisi B; Orr J; Grendys E; Boothby R; DeCesare S; LaPolla J; Hoffman M; Patel J
    Gynecol Oncol; 2002 Apr; 85(1):89-94. PubMed ID: 11925125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Phase II study of topotecan in patients with squamous cell carcinoma of the cervix: a gynecologic oncology group study.
    Muderspach LI; Blessing JA; Levenback C; Moore JL
    Gynecol Oncol; 2001 May; 81(2):213-5. PubMed ID: 11354055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: a gynecologic oncology group study.
    Moore DH; Blessing JA; McQuellon RP; Thaler HT; Cella D; Benda J; Miller DS; Olt G; King S; Boggess JF; Rocereto TF
    J Clin Oncol; 2004 Aug; 22(15):3113-9. PubMed ID: 15284262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cisplatin and irinotecan in squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group.
    Muggia FM; Blessing JA; McGehee R; Monk BJ
    Gynecol Oncol; 2004 Aug; 94(2):483-7. PubMed ID: 15297192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II study of irinotecan (CPT-11) in children with high-risk malignant brain tumors: the Duke experience.
    Turner CD; Gururangan S; Eastwood J; Bottom K; Watral M; Beason R; McLendon RE; Friedman AH; Tourt-Uhlig S; Miller LL; Friedman HS
    Neuro Oncol; 2002 Apr; 4(2):102-8. PubMed ID: 11916501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II evaluation of altretamine for advanced or recurrent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study.
    Rose PG; Blessing JA; Arseneau J
    Gynecol Oncol; 1996 Jul; 62(1):100-2. PubMed ID: 8690279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged oral etoposide in recurrent or advanced non-squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study.
    Rose PG; Blessing JA; Buller RE; Mannel RS; Webster KD
    Gynecol Oncol; 2003 May; 89(2):267-70. PubMed ID: 12713990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II study of vinblastine in previously treated squamous carcinoma of the cervix. A Gynecologic Oncology Group study.
    Sutton GP; Blessing JA; Barnes W; Ball H
    Am J Clin Oncol; 1990 Dec; 13(6):470-1. PubMed ID: 2239800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of vinorelbine in persistent or recurrent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study.
    Muggia FM; Blessing JA; Method M; Miller DS; Johnson GA; Lee RB; Menzin A;
    Gynecol Oncol; 2004 Feb; 92(2):639-43. PubMed ID: 14766259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.